{"transactions":[{"id":725419,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T21:54:46.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":31746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 24, 2027."}],"balance_after":31746,"derivative":{"exercise_price":3.45,"exercise_date":"2027-06-24","expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":31746},"source":{"system":"sec-edgar","filing":"0001437237-26-000001","document":"wk-form4_1782510883.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000143723726000001/wk-form4_1782510883.xml","form_type":"4"}},{"id":1101635,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T00:23:40.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 24, 2026."}],"balance_after":20000,"derivative":{"exercise_price":14.13,"exercise_date":"2026-06-24","expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-25-033057","document":"wk-form4_1750897416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828025033057/wk-form4_1750897416.xml","form_type":"4"}},{"id":1332222,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Options (right to buy)","published_at":"2024-12-14T00:12:16.000Z","date":"2024-12-13","kind":"exercise","planned":false,"acquired":false,"shares":50001,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.66,"exercise_date":"2016-07-06","expiration_date":"2025-07-05","underlying":"Common Stock","underlying_shares":50001},"source":{"system":"sec-edgar","filing":"0001628280-24-051264","document":"wk-form4_1734135129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828024051264/wk-form4_1734135129.xml","form_type":"4"}},{"id":1332221,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-14T00:12:16.000Z","date":"2024-12-13","kind":"sale","planned":false,"acquired":false,"shares":37161,"price":6.1881,"value":229955.9841,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $6.1881, and the range of prices were between $6.13 and $6.285. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sale of shares was solely to cover the exercise cost and associated taxes for the exercise of the options which were scheduled to expire on July 5, 2025.  As a result of the exercise of the options, the Reporting Person will own 12,840 more shares."}],"balance_after":244179,"source":{"system":"sec-edgar","filing":"0001628280-24-051264","document":"wk-form4_1734135129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828024051264/wk-form4_1734135129.xml","form_type":"4"}},{"id":1332220,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-14T00:12:16.000Z","date":"2024-12-13","kind":"exercise","planned":false,"acquired":true,"shares":50001,"price":3.66,"value":183003.66,"ownership":{"direct":true},"balance_after":281340,"source":{"system":"sec-edgar","filing":"0001628280-24-051264","document":"wk-form4_1734135129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828024051264/wk-form4_1734135129.xml","form_type":"4"}},{"id":1471941,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T22:14:05.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 20, 2025."}],"balance_after":20000,"derivative":{"exercise_price":2.71,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-24-029397","document":"wk-form4_1719008038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828024029397/wk-form4_1719008038.xml","form_type":"4"}},{"id":1851970,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:23:15.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 15, 2024."}],"balance_after":20000,"derivative":{"exercise_price":1.67,"exercise_date":"2024-06-15","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-23-022522","document":"wk-form4_1686950586.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828023022522/wk-form4_1686950586.xml","form_type":"4"}},{"id":1857131,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T20:50:09.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":1.69,"value":11830.0,"ownership":{"direct":true},"balance_after":231339,"source":{"system":"sec-edgar","filing":"0001628280-23-021978","document":"wk-form4_1686689397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828023021978/wk-form4_1686689397.xml","form_type":"4"}},{"id":2382076,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Employee Stock Options (right to buy)","published_at":"2022-02-22T22:31:01.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":107805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares subject to the option shall vest on February 17, 2023 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":107805,"derivative":{"exercise_price":2.67,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":107805},"source":{"system":"sec-edgar","filing":"0001628280-22-003374","document":"wf-form4_164556903170946.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000162828022003374/wf-form4_164556903170946.xml","form_type":"4"}},{"id":2781938,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Employee Stock Options (right to buy)","published_at":"2021-03-17T22:46:15.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":25072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on March 15, 2022 and thereafter 1/36th vest each month."}],"balance_after":25072,"derivative":{"exercise_price":11.83,"exercise_date":"2022-03-15","expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":25072},"source":{"system":"sec-edgar","filing":"0001415889-21-001550","document":"form4-03172021_030304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588921001550/form4-03172021_030304.xml","form_type":"4"}},{"id":2948569,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Employee Stock Options (right to buy)","published_at":"2020-12-11T22:06:22.000Z","date":"2020-12-10","kind":"exercise","acquired":false,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.62,"exercise_date":"2012-05-10","expiration_date":"2021-05-10","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001415889-20-002874","document":"form4-12112020_021211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588920002874/form4-12112020_021211.xml","form_type":"4"}},{"id":2948568,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Common Stock","published_at":"2020-12-11T22:06:22.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":37829,"price":5.19,"value":196332.51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $5.19, and the range of prices were between $5.15 and $5.25.  Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The shares were sold to cover the cost of the exercise of the options which were scheduled to expire on May 10, 2021."}],"balance_after":224339,"source":{"system":"sec-edgar","filing":"0001415889-20-002874","document":"form4-12112020_021211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588920002874/form4-12112020_021211.xml","form_type":"4"}},{"id":2948567,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Common Stock","published_at":"2020-12-11T22:06:22.000Z","date":"2020-12-10","kind":"exercise","acquired":true,"shares":41667,"price":4.62,"value":192501.54,"ownership":{"direct":true},"balance_after":262168,"source":{"system":"sec-edgar","filing":"0001415889-20-002874","document":"form4-12112020_021211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588920002874/form4-12112020_021211.xml","form_type":"4"}},{"id":2989633,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Employee Stock Options (right to buy)","published_at":"2020-11-06T21:14:26.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":74048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 Amendment is being filed solely to add the Power of Attorney."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest 33% on February 25, 2021 and thereafter 1/36th vest each month."}],"balance_after":74048,"derivative":{"exercise_price":3.27,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":74048},"source":{"system":"sec-edgar","filing":"0001415889-20-002556","document":"form4a-11062020_011116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588920002556/form4a-11062020_011116.xml","form_type":"4/A","original_submission_date":"2020-02-27"}},{"id":3243775,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Employee Stock Options (right to buy)","published_at":"2020-02-28T01:30:31.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":74048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on February 25, 2021 and thereafter 1/36th vest each month."}],"balance_after":74048,"derivative":{"exercise_price":3.27,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":74048},"source":{"system":"sec-edgar","filing":"0001415889-20-000548","document":"form4-02272020_050217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588920000548/form4-02272020_050217.xml","form_type":"4"}},{"id":3599279,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Employee Stock Options (right to buy)","published_at":"2019-03-13T00:50:57.000Z","date":"2019-03-11","kind":"exercise","acquired":false,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2010-05-13","expiration_date":"2019-05-13","underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001415889-19-000308","document":"form4-03122019_050344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588919000308/form4-03122019_050344.xml","form_type":"4"}},{"id":3599278,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Common Stock","published_at":"2019-03-13T00:50:57.000Z","date":"2019-03-11","kind":"sale","acquired":false,"shares":14390,"price":3.5,"value":50365.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $3.50, and the range of prices were between $3.47 and $3.53. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The shares were sold to cover the cost of the exercise of the options which were scheduled to expire on May 13, 2019."}],"balance_after":220501,"source":{"system":"sec-edgar","filing":"0001415889-19-000308","document":"form4-03122019_050344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588919000308/form4-03122019_050344.xml","form_type":"4"}},{"id":3599277,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Common Stock","published_at":"2019-03-13T00:50:57.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":33334,"price":1.5,"value":50001.0,"ownership":{"direct":true},"balance_after":234891,"source":{"system":"sec-edgar","filing":"0001415889-19-000308","document":"form4-03122019_050344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588919000308/form4-03122019_050344.xml","form_type":"4"}},{"id":3638621,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN OF BOARD"}}],"security":"Employee Stock Options (right to buy)","published_at":"2019-02-23T00:39:10.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":55040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on February 21, 2020 and thereafter 1/36th vest each month."}],"balance_after":55040,"derivative":{"exercise_price":3.84,"exercise_date":"2020-02-21","expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":55040},"source":{"system":"sec-edgar","filing":"0001415889-19-000223","document":"form4-02222019_040257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588919000223/form4-02222019_040257.xml","form_type":"4"}},{"id":3930739,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-05-16T20:59:33.000Z","date":"2018-05-16","kind":"purchase","acquired":true,"shares":4300,"price":3.56,"value":15308.0,"ownership":{"direct":true},"balance_after":211357,"source":{"system":"sec-edgar","filing":"0001415889-18-000754","document":"form4-05162018_010520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000754/form4-05162018_010520.xml","form_type":"4"}},{"id":3930738,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-05-16T20:59:33.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":5500,"price":3.61,"value":19855.0,"ownership":{"direct":true},"balance_after":207057,"source":{"system":"sec-edgar","filing":"0001415889-18-000754","document":"form4-05162018_010520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000754/form4-05162018_010520.xml","form_type":"4"}},{"id":3976353,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2018-04-02T20:39:53.000Z","date":"2018-03-29","kind":"exercise","acquired":false,"shares":474,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":171503,"derivative":{"exercise_price":4.5,"exercise_date":"2009-04-21","expiration_date":"2018-04-21","underlying":"Common Stock","underlying_shares":474},"source":{"system":"sec-edgar","filing":"0001415889-18-000499","document":"form4-04022018_010440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000499/form4-04022018_010440.xml","form_type":"4"}},{"id":3976352,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-04-02T20:39:53.000Z","date":"2018-03-29","kind":"sale","acquired":false,"shares":474,"price":4.6,"value":2180.4,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on March 16, 2018. The options exercised and sold were scheduled to expire on April 21, 2018."}],"balance_after":201557,"source":{"system":"sec-edgar","filing":"0001415889-18-000499","document":"form4-04022018_010440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000499/form4-04022018_010440.xml","form_type":"4"}},{"id":3976351,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-04-02T20:39:53.000Z","date":"2018-03-29","kind":"exercise","acquired":true,"shares":474,"price":4.5,"value":2133.0,"ownership":{"direct":true},"balance_after":202031,"source":{"system":"sec-edgar","filing":"0001415889-18-000499","document":"form4-04022018_010440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000499/form4-04022018_010440.xml","form_type":"4"}},{"id":3979644,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2018-03-29T21:03:22.000Z","date":"2018-03-27","kind":"exercise","acquired":false,"shares":24578,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":171977,"derivative":{"exercise_price":4.5,"exercise_date":"2009-04-21","expiration_date":"2018-04-21","underlying":"Common Stock","underlying_shares":24578},"source":{"system":"sec-edgar","filing":"0001415889-18-000453","document":"form4-03292018_020309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000453/form4-03292018_020309.xml","form_type":"4"}},{"id":3979643,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-03-29T21:03:22.000Z","date":"2018-03-27","kind":"sale","acquired":false,"shares":24578,"price":4.6,"value":113058.8,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on March 16, 2018. The options exercised and sold were scheduled to expire on April 21, 2018."}],"balance_after":201557,"source":{"system":"sec-edgar","filing":"0001415889-18-000453","document":"form4-03292018_020309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000453/form4-03292018_020309.xml","form_type":"4"}},{"id":3979642,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-03-29T21:03:22.000Z","date":"2018-03-27","kind":"exercise","acquired":true,"shares":24578,"price":4.5,"value":110601.0,"ownership":{"direct":true},"balance_after":226135,"source":{"system":"sec-edgar","filing":"0001415889-18-000453","document":"form4-03292018_020309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000453/form4-03292018_020309.xml","form_type":"4"}},{"id":4092325,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2018-01-23T21:18:05.000Z","date":"2018-01-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% on January 21, 2019 and thereafter 1/48th vest each month."}],"balance_after":50000,"derivative":{"exercise_price":5.85,"exercise_date":"2019-01-21","expiration_date":"2028-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-18-000104","document":"form4-01232018_010152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000104/form4-01232018_010152.xml","form_type":"4"}},{"id":4100445,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2018-01-12T21:56:43.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":6249,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":196555,"derivative":{"exercise_price":4.5,"exercise_date":"2009-04-21","expiration_date":"2018-04-21","underlying":"Common Stock","underlying_shares":6249},"source":{"system":"sec-edgar","filing":"0001415889-18-000047","document":"form4-01122018_010129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000047/form4-01122018_010129.xml","form_type":"4"}},{"id":4100444,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2018-01-12T21:56:43.000Z","date":"2018-01-10","kind":"exercise","acquired":false,"shares":22130,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":202804,"derivative":{"exercise_price":4.5,"exercise_date":"2009-04-21","expiration_date":"2018-04-21","underlying":"Common Stock","underlying_shares":22130},"source":{"system":"sec-edgar","filing":"0001415889-18-000047","document":"form4-01122018_010129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000047/form4-01122018_010129.xml","form_type":"4"}},{"id":4100443,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-12T21:56:43.000Z","date":"2018-01-11","kind":"sale","acquired":false,"shares":6249,"price":6.5,"value":40618.5,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on November 17, 2017. The options exercised and sold were scheduled to expire on April 21, 2018 and Mr. Jaksch sold the shares so that the proceeds can be used to cover the exercise payment and applicable withholding taxes due."}],"balance_after":201557,"source":{"system":"sec-edgar","filing":"0001415889-18-000047","document":"form4-01122018_010129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000047/form4-01122018_010129.xml","form_type":"4"}},{"id":4100442,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-12T21:56:43.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":6249,"price":4.5,"value":28120.5,"ownership":{"direct":true},"balance_after":207806,"source":{"system":"sec-edgar","filing":"0001415889-18-000047","document":"form4-01122018_010129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000047/form4-01122018_010129.xml","form_type":"4"}},{"id":4100441,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-12T21:56:43.000Z","date":"2018-01-10","kind":"sale","acquired":false,"shares":22130,"price":6.52,"value":144287.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $6.52, and the range of prices were between $6.50 and $6.58.  Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on November 17, 2017. The options exercised and sold were scheduled to expire on April 21, 2018 and Mr. Jaksch sold the shares so that the proceeds can be used to cover the exercise payment and applicable withholding taxes due."}],"balance_after":201557,"source":{"system":"sec-edgar","filing":"0001415889-18-000047","document":"form4-01122018_010129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000047/form4-01122018_010129.xml","form_type":"4"}},{"id":4100440,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-01-12T21:56:43.000Z","date":"2018-01-10","kind":"exercise","acquired":true,"shares":22130,"price":4.5,"value":99585.0,"ownership":{"direct":true},"balance_after":223687,"source":{"system":"sec-edgar","filing":"0001415889-18-000047","document":"form4-01122018_010129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588918000047/form4-01122018_010129.xml","form_type":"4"}},{"id":4121627,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2017-12-26T21:34:36.000Z","date":"2017-12-21","kind":"exercise","acquired":false,"shares":58400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":224934,"derivative":{"exercise_price":4.5,"exercise_date":"2009-04-21","expiration_date":"2018-04-21","underlying":"Common Stock","underlying_shares":58400},"source":{"system":"sec-edgar","filing":"0001415889-17-002002","document":"form4-12262017_011223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588917002002/form4-12262017_011223.xml","form_type":"4"}},{"id":4121626,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-26T21:34:36.000Z","date":"2017-12-21","kind":"sale","acquired":false,"shares":58400,"price":6.19,"value":361496.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on November 17, 2017.  The options exercised and sold were scheduled to expire on April 21, 2018 and Mr. Jaksch sold the shares so that the proceeds can be used to cover the exercise payment and applicable withholding taxes due."}],"balance_after":201557,"source":{"system":"sec-edgar","filing":"0001415889-17-002002","document":"form4-12262017_011223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588917002002/form4-12262017_011223.xml","form_type":"4"}},{"id":4121625,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-26T21:34:36.000Z","date":"2017-12-21","kind":"exercise","acquired":true,"shares":58400,"price":4.5,"value":262800.0,"ownership":{"direct":true},"balance_after":259957,"source":{"system":"sec-edgar","filing":"0001415889-17-002002","document":"form4-12262017_011223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588917002002/form4-12262017_011223.xml","form_type":"4"}},{"id":4525497,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":35127,"kind":"person","name":"Jaksch Frank L Jr","position":1,"cik":"0001437237","reported_name":"Jaksch Frank L Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, PRESIDENT"}}],"security":"Common Stock","published_at":"2016-12-12T21:58:18.000Z","date":"2016-12-12","kind":"purchase","acquired":true,"shares":2000,"price":2.42,"value":4840.0,"ownership":{"direct":true},"balance_after":201557,"source":{"system":"sec-edgar","filing":"0001415889-16-007569","document":"form4-12122016_011209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437237/000141588916007569/form4-12122016_011209.xml","form_type":"4"}}]}